3 hours Zevra Therapeutics (NASDAQ:ZVRA) Coverage Initiated at Guggenheim MarketBeat
Guggenheim assumed coverage on Zevra Therapeutics in a report on Monday. They issued a “buy” rating and a $20.00 price target for the company.
Guggenheim assumed coverage on Zevra Therapeutics in a report on Monday. They issued a “buy” rating and a $20.00 price target for the company.